This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brandish, P. E.
Right arrow Articles by Bugg, T. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brandish, P. E.
Right arrow Articles by Bugg, T. D.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, 07 1996, 1640-1644, Vol 40, No. 7
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Modes of action of tunicamycin, liposidomycin B, and mureidomycin A: inhibition of phospho-N-acetylmuramyl-pentapeptide translocase from Escherichia coli

PE Brandish, KI Kimura, M Inukai, R Southgate, JT Lonsdale and TD Bugg
Department of Chemistry, University of Southampton, Highfield, United Kingdom.

Using a continuous fluorescence-based enzyme assay, we have characterized the antibacterial agents tumicamycin and liposidomycin B as inhibitors of solubilized Escherichia coli phospho-N-acetylmuramyl- pentapeptide translocase. Tunicamycin exhibited reversible inhibition (Ki = 0.55 +/- 0.1 microM) which was noncompetitive with respect to the lipid acceptor substrate and competitive with respect to the fluorescent substrate analog, dansyl-UDPMurNAc-pentapeptide. Liposidomycin B exhibited slow-binding inhibition (Ki = 80 +/- 15 nM) which was competitive with respect to the lipid acceptor substrate and noncompetitive with respect to dansyl-UDPMurNAc-pentapeptide. These results provide insight into the molecular mechanisms of action of these two classes of nucleoside antibiotics.


This article has been cited by other articles:

  • Pereira, M. P., Blanchard, J. E., Murphy, C., Roderick, S. L., Brown, E. D. (2009). High-Throughput Screening Identifies Novel Inhibitors of the Acetyltransferase Activity of Escherichia coli GlmU. Antimicrob. Agents Chemother. 53: 2306-2311 [Abstract] [Full Text]  
  • Kaysser, L., Lutsch, L., Siebenberg, S., Wemakor, E., Kammerer, B., Gust, B. (2009). Identification and Manipulation of the Caprazamycin Gene Cluster Lead to New Simplified Liponucleoside Antibiotics and Give Insights into the Biosynthetic Pathway. J. Biol. Chem. 284: 14987-14996 [Abstract] [Full Text]  
  • Mendel, S., Holbourn, J. M., Schouten, J. A., Bugg, T. D. H. (2006). Interaction of the transmembrane domain of lysis protein E from bacteriophage {phi}X174 with bacterial translocase MraY and peptidyl-prolyl isomerase SlyD.. Microbiology 152: 2959-2967 [Abstract] [Full Text]  
  • Ramachandran, V., Chandrakala, B., Kumar, V. P., Usha, V., Solapure, S. M., de Sousa, S. M. (2006). Screen for Inhibitors of the Coupled Transglycosylase-Transpeptidase of Peptidoglycan Biosynthesis in Escherichia coli.. Antimicrob. Agents Chemother. 50: 1425-1432 [Abstract] [Full Text]  
  • Price, N. P., Momany, F. A. (2005). Modeling bacterial UDP-HexNAc: polyprenol-P HexNAc-1-P transferases. Glycobiology 15: 29R-42R [Abstract] [Full Text]  
  • Solapure, S. M., Raphael, P., Gayathri, C. N., Barde, S. P., Chandrakala, B., Das, K. S., deSousa, S. M. (2005). Development of a Microplate-Based Scintillation Proximity Assay for MraY Using a Modified Substrate. J Biomol Screen 10: 149-156 [Abstract]  
  • Bouhss, A., Crouvoisier, M., Blanot, D., Mengin-Lecreulx, D. (2004). Purification and Characterization of the Bacterial MraY Translocase Catalyzing the First Membrane Step of Peptidoglycan Biosynthesis. J. Biol. Chem. 279: 29974-29980 [Abstract] [Full Text]  
  • Lloyd, A. J., Brandish, P. E., Gilbey, A. M., Bugg, T. D. H. (2004). Phospho-N-Acetyl-Muramyl-Pentapeptide Translocase from Escherichia coli: Catalytic Role of Conserved Aspartic Acid Residues. J. Bacteriol. 186: 1747-1757 [Abstract] [Full Text]  
  • Stachyra, T., Dini, C., Ferrari, P., Bouhss, A., van Heijenoort, J., Mengin-Lecreulx, D., Blanot, D., Biton, J., Le Beller, D. (2004). Fluorescence Detection-Based Functional Assay for High-Throughput Screening for MraY. Antimicrob. Agents Chemother. 48: 897-902 [Abstract] [Full Text]  
  • Chandrakala, B., Shandil, R. K., Mehra, U., Ravishankar, S., Kaur, P., Usha, V., Joe, B., deSousa, S. M. (2004). High-Throughput Screen for Inhibitors of Transglycosylase and/or Transpeptidase Activities of Escherichia coli Penicillin Binding Protein 1b. Antimicrob. Agents Chemother. 48: 30-40 [Abstract] [Full Text]  
  • Chandrakala, B., Elias, B. C., Mehra, U., Umapathy, N. S., Dwarakanath, P., Balganesh, T. S., deSousa, S. M. (2001). Novel Scintillation Proximity Assay for Measuring Membrane-Associated Steps of Peptidoglycan Biosynthesis in Escherichia coli. Antimicrob. Agents Chemother. 45: 768-775 [Abstract] [Full Text]  
  • Bernhardt, T. G., Struck, D. K., Young, R. (2001). The Lysis Protein E of phi X174 Is a Specific Inhibitor of the MraY-catalyzed Step in Peptidoglycan Synthesis. J. Biol. Chem. 276: 6093-6097 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»